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ttp://dx.doi.org/10.1016/j.ajpath.2015.02.003Ischemic acute kidney injury is a serious untreatable condition. Activation of the G protein a12 (Ga12)
subunit by reactive oxygen species is a major cause of tissue damage during renal ischemia-reperfusion
injury. Kidney injury molecule-1 (KIM-1) is a transmembrane glycoprotein that is highly up-regulated
during acute kidney injury, but the physiologic signiﬁcance of this up-regulation is unclear. Here, we
report for the ﬁrst time that Kim-1 inhibits Ga12 activation and protects mice against renal ischemia-
reperfusion injury.We reveal that Kim-1 physically interacts with and inhibits cellular Ga12 activation after
inﬂammatory stimuli, including reactive oxygen species, by blocking GTP binding to Ga12. Compared with
Kim-1þ/þ mice, Kim-1/ mice exhibited greater Ga12 and downstream Src activation both in primary
tubular epithelial cells after in vitro stimulation with H2O2 and in whole kidneys after unilateral renal artery
clamping. Finally, we show that Kim-1edeﬁcient mice had more severe kidney dysfunction and tissue
damage after bilateral renal artery clamping, comparedwith wild-typemice. Our results suggest that KIM-1
is an endogenous protective mechanism against renal ischemia-reperfusion injury through inhibition of
Ga12. (Am J Pathol 2015, 185: 1207e1215; http://dx.doi.org/10.1016/j.ajpath.2015.02.003)Supported by Canadian Institutes of Health Research grants HDK 232429
and 244945 (L.G.), NIH grant GM55223 (B.M.D.), Lawson Studentship
(O.Z.I.), KRESCENT and AMOSO salary awards (L.G.), and Junior 1
scholarship award from the Fonds de Recherche duQuébece Santé (R.A.S.).
Disclosures: None declared.Acute kidney injury (AKI) is a serious medical condition that
most often results from ischemia-reperfusion injury (IRI) and
for which there is no effective treatment.1,2 Kidney injury
molecule-1 (KIM-1) is a cell-surface glycoprotein receptor3
that is speciﬁcally up-regulated on the apical surface of
proximal tubular epithelial cells (TECs) after AKI.4 It is a
highly sensitive and speciﬁc biomarker of tubular injury that is
virtually absent in healthy kidneys.5 Both mouse and human
KIM-1 (also known as T-cell immunoglobulin, mucin
domain-1 protein and hepatitis A virus cellular receptor-1) are
small type I transmembrane glycoproteins that belong to the
T-cell immunoglobulin mucin gene family.3 Structurally,
KIM-1 is made up of an IgV-like domain, a mucin-like
domain, a transmembrane domain, and an intracellular
domain that is implicated in T-cell signaling.6,7 The patho-
physiologic role ofKIM-1 signaling inAKI remains unknown.stigative Pathology.
.Here, we reveal a novel interaction between KIM-1 and G
protein a-12 (Ga12). Ga12 is a ubiquitously expressed G
protein that belongs to the G12 family of G proteins that
has pleiotropic effects on cells, including inducing prolifer-
ation, focal adhesion assembly, cytoskeletal reorganization,
apoptosis, and disruption of tight junctions.8 Recently, Yu
et al9 demonstrated that activated Ga12 is a pivotal mediator
of TEC injury caused by ischemia-reperfusion. Reactive ox-
ygen species (ROSs) that are generated during ischemia-
reperfusion stimulate Ga12 to activate Src-dependent injury
Ismail et alpathways. Speciﬁcally, Ga12-deﬁcient mice were protected
from renal IRI, whereas mice with TEC-speciﬁc transgenic
overexpression of constitutively active Ga12 exhibited worse
tissue damage and delayed recovery after IRI.9 Given the
relevance of KIM-1 and Ga12 in AKI, we investigated the
biological interaction between these proteins by using in vitro
and in vivo models of ischemic AKI.
Materials and Methods
Animal Preparation and Induction of IRI
All mouse experiments were performed according to the an-
imal experimental guidelines issued by the Animal Care and
Use Committee at Western University. C57BL/6 wild-type
(Kim-1þ/þ) mice were obtained from the Charles Rivers
Laboratory (Wilmington, MA). Kim-1 (Havcr1) knockout
(Kim-1/) mice were generously provided by Dr. Andrew
N.J. McKenzie (MRC Laboratory of Molecular Biology,
Cambridge, UK). The Kim-1/ mice were generated using
C57BL/6 embryos and backcrossed over six generations to the
C57BL/6 strain, and homozygous Kim-1/ were obtained by
interbreeding the heterozygotes (Kim-1þ/). Genomic DNA
was isolated frommice tail digests, andgenotypeswere screened
with PCR by using primers ASEQ965 50-ATATCTCAG-
GAATGGGATTGTGAC-30 and ASEQ966 50-CTACTGTA-
TTTAACTGATTTGAAG-30. Six- to 9-week-old male Kim-
1þ/þ or Kim-1/mice that weighed 20 to 25 g were subjected
to unilateral or bilateral renal pedicle ligation for 25 to 35
minutes (as indicated) at 32C, as described previously.10 To
assess Ga12 activity in the ischemic and contralateral kidneys,
after reperfusions, the kidneyswere removed after being ﬂushed
with cold phosphate-buffered saline. Shamcontrolswere treated
with the same operative procedure as in the injury group, but
kidneys were not clamped.
Renal Function and Histology
Serum creatinine was detected by a Jaffe reaction method
with an automated CX5 clinic analyzer (Beckman, Pasa-
dena, CA). Kidney sections (5 to 6 mm) from animals at 24
and 48 hours after reperfusion or sham surgery were stained
with periodic acid-Schiff by a trained pathologist (A.H.),
and the degree of tubular injury was graded by light mi-
croscopy by the same pathologist blinded to mouse strain by
using an arbitrary scale that examined proximal tubule
dilation, brush-border damage, proteinaceous casts, inter-
stitial widening, and necrosis (0, none; 1, <11%; 2, 11% to
25%; 3, 26% to 45%; 4, 46% to 75%; 5, >75%).
Mass Spectrometry
KIM-1 immune complexes were derived from human
embryonic kidney (HEK)-293 cells stably overexpressing
hemagglutinin (HA)-tagged KIM-17 or vector alone.11
Plasmid-expressing KIM-1-HA was a kind gift from1208Dr. Joseph Bonventre (Brigham and Women’s Hospital,
Harvard Medical School, Boston, MA), and it was generated
in a similar manner as described before.7 Brieﬂy, the full-
length human KIM-1 with an N-terminal HA tag was gener-
ated with PCR by using phKIM1.2 as template and then
subcloned into the EcoRV sites of eukaryotic expression
vector pcDNA3 (Invitrogen, Carlsbad, CA). On transfection of
KIM-1-HA, protein and surface expression were comparable
with endogenous KIM-1 expressed in human renal adeno-
carcinoma cells (Supplemental Figure S1, A and B). Immu-
noprecipitation (IP) was done with anti-HA antibody (Santa
Cruz Biotechnology, Santa Cruz, CA). SDS-PAGE was used
to identify unique bands that co-immunoprecipitated with
KIM-1, and a target protein band of approximately 38 kDawas
excised and subjected to in-gel tryptic digestion, followed by
mass spectrometry (microcapillary liquid chromatography/
tandem mass spectrometry) and analyzed by the Taplin mass
spectrometry facility (Harvard Medical School, Boston, MA).
Cell Lines and Culture
HEK-293 cells stably expressing control vector or human
KIM-1were cultured at 37C in 5% (v/v) CO2 andmaintained
in Dulbecco’s modiﬁed Eagle’s medium (Invitrogen) that
contained 5% (v/v) fetal bovine serum and 800 mg/mL
geneticin (G418) sulfate (Santa Cruz Biotechnology).
Expression of KIM-1 was conﬁrmed by Western blot anal-
ysis. HEK-293 cells were transfected with a truncated version
of KIM-1 that contained its cytosolic domain fused to trans-
membrane domain (kind gift from Dr. Joseph Bonventre,
Brigham andWomen’s Hospital, HarvardMedical School) by
using lipofectamine 2000 (Invitrogen). Brieﬂy, this plasmid
was generated with PCR by using Not1 restriction sites of
human KIM-1 plasmid.7 The resulting construct that con-
tained the transmembrane and cytosolic domain of KIM-1
was subcloned into pFLAG-CMV-3 (Sigma-Aldrich, St.
Louis, MO). The expression of the construct was conﬁrmed
with Western blot analysis (Supplemental Figure S1C). Kid-
neys isolated from 3- to 4-week-old C57BL/6 wild-type
(Kim-1þ/þ) or Kim-1/ mice were cultured to select for
proximal TECs as described previously.12 Brieﬂy, kidneys
were homogenized, and the cells isolatedwere cultured for the
ﬁrst 6 days in serum-free Dulbecco’s modiﬁed Eagle’s
medium/F-12 mixed media (1:1; Invitrogen) supplemented
with 5% insulin-transferrin-selenium solution, 5% penicillin-
streptomycin solution (Invitrogen), 0.5 mg/mL mouse
epidermal growth factor (PeproTech, Rocky Hill, NJ), and
50 ng/mL hydrocortisone (Invitrogen). After 6 days, cells were
cultured with the same media mixture supplemented with 5%
fetal bovine serum.12
Western Blot Analysis
Conﬂuent monolayer of cell lines (HEK-293 or primary
TECs) or kidney cortices were homogenized and lyzed in ice-
cold lysis buffer and were centrifuged at 15,000  g for 10ajp.amjpathol.org - The American Journal of Pathology
Table 1 Selected Homo sapiens KIM-1 Interacting Proteins
Interacting proteins Accession number
Guanine nucleotide-binding protein, a-12 subunit (Ga12) Q03113
Arginase 1 (liver-type arginase) P05089
Set protein (phosphatase 2a inhibitor i2pp2a) template activating factor i (Taf-i) Q01105
Fructose-bisphosphate aldolase c P09972
Nucleophosmin numatrin P06748
KIM-1 Protects Against Renal IRIminutes. The supernatant ﬂuid was collected for Western blot
analysis. Protein concentrations were determined by Pierce
BCA Protein Assay Kit (Thermo Fisher Scientiﬁc, Rockford,
IL), and 50 mg of protein was used as input for the experi-
ment. Proteins (1000 mg) were used for IP or glutathione S-
transferase (GST)efused tetratricopeptide repeat (TPR)
domain of Ser/Thr protein phosphatase type 5 (GST-TPR)
pull-down experiments. Input and immuneprecipitated sam-
ples were electrophoresed on 4% to 20% Mini-PROTEAN
TGX gels (Bio-Rad Laboratories, Hercules, CA) and trans-
ferred to a polyvinylidene diﬂuoride membrane (Millipore,
Billerica, MA). Membranes were blocked with blocking
buffer [(tris-buffered saline, 0.1% Tween-20, and either 5%
nonfat dried milk (Bioshop, Burlington, ON, Canada) or 5%
bovine serum albumin solution (Sigma-Aldrich)] for 30 mi-
nutes and were then incubated overnight at 4C with one of
the following primary antibodies: cytosolic domain of human
KIM-1 (custom antibody; Thermo Fisher Scientiﬁc),4 extra-
cellular domain of human KIM-1 (Dr. Bonventre, Harvard
Medical School),13 extracellular domain of mouse Kim-1
(AF1817; R&D Systems, Minneapolis, MN), Ga12/actin/
glyceraldehyde-3-phosphate dehydrogenase or c-Src (Santa
Cruz Biotechnology), or active Src (pY419-Src) antibody
(Invitrogen). Membranes were washed and incubated with
the appropriate horseradish peroxidase-conjugated secondary
antibody (dilution 1:30,000; Jackson ImmunoResearch
Laboratories, West Grove, PA) for 1 hour at room tempera-
ture in blocking buffer. Proteins were visualized with Super-
Signal West Femto chemiluminescent substrate (Thermo
Fisher Scientiﬁc). The resulting protein bands were detected
by autoradiography (Biomax; Denville Scientiﬁc, South
Plainﬁeld, NJ) and were scanned with a Brother scanner
(Brother Electronics, Dollard-des-Ormeaux,QC, Canada), and
the integrated density of each protein band was determined
with ImageJ software version 1.49p (NIH, Bethesda, MD).
Each densiometric graph represents at least three independent
experimental results. To normalize for protein loading, the
integrated density of each band was divided by the integrated
density of the actin band in the same lane from the same
membrane.14
IP and GST-Ga12 Pull-Down Assay
For IP, cells were lyzed with ice-cold lysis buffer [25 mmol/L
HEPES (Sigma-Aldrich), 150 mmol/L NaCl, 15 mmol/L
MgCl2, 1% Triton X-100, and Mini-protease inhibitors tablet
(Roche Diagnostic, Basel, Switzerland)].15 After protein
quantiﬁcation, IP of 1000 mg of lysates was done withThe American Journal of Pathology - ajp.amjpathol.organtibodies against Ga12, the cytosolic domain of KIM-1,7 or
rabbit IgG control (Santa Cruz Biotechnology) and protein-
A/G Sepharose beads (Santa Cruz Biotechnology). Lysates
(representing 5% of total lysate) and IP samples were
analyzed by SDS-PAGE and Western blot analysis as
described in Western Blot Analysis. For GST-Ga12 pull-
down, KIM-1-HA was in vitro translated and S35-labled in
rabbit reticulocyte lysates as described previously.16 Protein
lysates were incubated with GST-Ga12 or GST alone and
eluted after 3 hours of incubation. Samples were analyzed
by SDS-PAGE and autoradiography (Biomax; Denville
Scientiﬁc, Metuchen, NJ).
Ga12 Activation Assay (GST-TPR Pull Down)
A construct of GST-fused TPR domain of Ser/Thr protein
phosphatase type 5 was kindly provided by Dr. Danny N.
Dhanasekaran (Temple University, Philadelphia, PA).16
GST-TPR was puriﬁed from Escherichia coli and was
conjugated to glutathione-agarose beads (Thermo Fisher
Scientiﬁc) as described.17 GST-TPReconjugated beads
were freshly made for each experiment. Kidney homoge-
nates after IRI or cells unstimulated, stimulated with 5
mmol/L H2O2 (Bio Basic, Amherst, NY) or 2 U/mL
a-thrombin (Enzyme Research Laboratories, South Bend, IN)
were lyzed with ice-cold lysis buffer [50 mmol/L HEPES (at
pH 7.5) (Sigma-Aldrich), 1 mmol/L EDTA, 3 mmol/L
dithiothreitol, 2 mmol/L MgSO4, 1% polyoxyethylene (10)
lauryl ether (C12E10), and mini-protease inhibitor tablet
(Roche Diagnostic, Basel, Switzerland)].9 Supernatant ﬂuids
that contained 1 mg of the protein were incubated with GST-
TPR coupled with glutathione-agarose beads at 4C for 5
hours.16 Where indicated, cell lysates were loaded with 1
mmol/L nonhydrolyzable GTP analog (GTPgS; Cytoskel-
eton, Denver, CO) after protein quantiﬁcation and were
incubated for 15 minutes at room temperature before adding
GST-TPR coupled with glutathione-agarose beads. Samples
were centrifuged at 5000  g for 5 minutes and washed with
1 phosphate-buffered saline twice before eluting the
bound active Ga12. Both 50 mg of protein (input) and pull-
down samples were analyzed by SDS-PAGE and Western
blot analysis by probing for Ga12 to represent total (input)
and active Ga12 (pull-down) in these samples.
Immunoﬂuorescence and Confocal Microscopy
HEK-293 cells were cultured at subconﬂuent density on
glass coverslips coated with poly-DL-lysine hydrobromide1209
Ismail et al(Sigma-Aldrich). Cells were transfected with green ﬂuores-
cent protein-tagged Ga12 construct18 by using lipofectamine
2000 (Invitrogen). Cells were ﬁxed with 4% paraformal-
dehyde (Sigma-Aldrich) and stained for surface KIM-1 by
using antibody against the extracellular domain of KIM-1
overnight at 4C. The slides were washed and incubated
with Alexa 555econjugated secondary antibody (Molecular
Probes, Invitrogen). Coverslips were mounted with Shandon-
Mount (Thermo Fisher Scientiﬁc) permanent mounting me-
dium. Mice kidneys after IRI were extracted and quartered.
The sections were ﬁxed in 4% paraformaldehyde overnightFigure 1 KIM-1 interacts with Ga12. A: Autoradiogram of pull-down with puriﬁ
KIM-1. B: IP of KIM-1 and Ga12 in lysates from HEK-293 cells stably expressing h
IgG control antibodies. C: Lysates of HEK-293 cells expressing truncated transme
antibodies. D: Lysates of HEK-293 cells stably expressing KIM-1 were pretreate
represents 5% of the lysate. Both lysates and IP samples were analyzed by SDS-PAG
and actin. Results represent three independent experiments. E: Colocalization of b
GFP-tagged Ga12 constructs. KIM-1 was detected with an antibody against its ext
mice that were immunoﬂuorescently stained with antieKim-1 (red) and anti-Ga12
for 24 hours. Arrows indicate areas of colocalization between KIM-1/Kim-1 and Ga
green ﬂuorescent protein; GST, glutathione S-transferase; GTPgS, nonhydrolyzab
precipitation; KIM-1, Kidney injury molecule-1.
1210for subsequent parafﬁn embedding. Kidney cortex sections
(10 mm) were sliced at 50-mm intervals by using a Leica
RM2125 microtome (Leica Microsystems, Buffalo Grove,
IL) and were mounted on glass slides. Sections were blocked
with 5% horse serum (Invitrogen) and hybridized overnight
at 4C with either extracellular domain of mouse Kim-1
(dilution 1:50; Sigma-Aldrich) or Ga12 (dilution 1:50;
Santa Cruz Biotechnology). Sections were then washed and
incubated with the appropriate ﬂuorophore-conjugated sec-
ondary antibodies (dilution 1:100; Invitrogen). All of the
sections were coverslipped with Shandon-Mount permanented GST-Ga12 or GST of in vitro translated S35-methionine-labeled HA-tagged
uman KIM-1 by using anti-Ga12, antieKIM-1 (against cytosolic), or rabbit
mbrane and cytosolic domain of KIM-1 were subjected to IP with indicated
d with GTPgS to activate Ga12 and then subjected to IP. The input lane
E and Western blot analysis for KIM-1 (against extracellular domain), Ga12,
oth KIM-1 and Ga12 proteins in HEK-293 cells cotransfected with KIM-1 and
racellular domain. F: Kidney cortex cross-section from wild-type (Kim-1þ/þ)
antibody after renal artery clamping for 30 minutes, followed by reperfusion
12. Original magniﬁcation: 600 (E); 400 (F). Ga12, G protein a-12; GFP,
le GTP; HA, hemagglutinin; HEK, human embryonic kidney; IP, immuno-
ajp.amjpathol.org - The American Journal of Pathology
Figure 2 KIM-1 inhibits cellular Ga12 activation by blocking GTP-binding. HEK-293 cells were transfected with either control vector (pcDNA) or KIM-1
plasmid. Cells were left untreated (A), stimulated with either 2 U/mL a-thrombin or 5 mmol/L H2O2 for 30 minutes (B), or treated with GTPgS for 15 minutes
(C). D: Conﬁrmation of genotype by using genomic DNA of wild-type (þ/þ), heterozygous (þ/), and homozygous Kim-1 knockout (/) C57BL/6mice by PCR.
TECs isolated from wild-type (Kim-1þ/þ) and Kim-1edeﬁcient (Kim-1/) mice were stimulated with GTPgS (E) or 5 mmol/L H2O2 for 30 minutes (F). Samples in
AeC, E, and Fwere subjected to GST-TPR pull-down assay tomeasure the amount of Ga12 activation. Lysates (total) and pull-down (active) samples were analyzed
by SDS-PAGE and Western analysis with antibodies against Ga12, human KIM-1 or mKim-1, and actin where indicated. G: Activated and total Src were detected in
total cell lysates from TECs stimulation with H2O2 by Western blot analysis by using antiep-Src (Py419-Src) phosphospeciﬁc antibody and antiec-Src antibody,
respectively. Densitometric analysis of the ratio of active to total Ga12 (or pY419-Src to c-Src) relative to noneKIM-1-expressing cells or wild-type TECs (þ/þ) is
shown as a representation the experiments. Data are expressed as means  SEM. nZ 3 independent experiments. *P < 0.05, **P < 0.01, and ***P < 0.001.
Ga12, G protein a-12; GST-TPR, glutathione S-transferaseefused tetratricopeptide repeat domain of Ser/Thr protein phosphatase type 5; GTPgS, nonhydrolyzable
GTP analog; HEK, human embryonic kidney; KIM-1, kidney injury molecule-1; mKim-1, mouse kidney injury molecule-1; TEC, tubular epithelial cell.
KIM-1 Protects Against Renal IRImounting medium before imaging. Samples were viewed with
FLUOVIEW X83I confocal microscopy (Olympus, Tokyo,
Japan). Data were acquired and analyzed with FLUOVIEW
FV10ASW4.0viewer (Olympus), and ImageJ software version
1.49p (NIH) was used to determine Pearson’s coefﬁcient for
colocalization of KIM-1 and Ga12. Quantiﬁcation of the num-
ber of colocalization scorewas assessed inﬁve randomﬁelds per
sample and was done in four independent experiments.
Statistical Analysis
Statistical analyses were done with Prism version 5.01
(GraphPad Software Inc., La Jolla, CA). Mean or median
differences between knockout and wild-type mice wereThe American Journal of Pathology - ajp.amjpathol.orgcompared with unpaired t-tests or U-tests as appropriate,
proportions were compared with c2 tests, and 95% CIs were
calculated with the method of Wilson.19 P < 0.05 was
considered signiﬁcant. Error bars represent the SEM unless
otherwise indicated.
Results
To identify putative signaling proteins downstream of KIM-1,
we performed mass spectrometric analysis on KIM-1 (anti-
HA) immunoprecipitates from HEK-293 cells stably over-
expressing KIM-1 fused to a c-terminal HA tag7 or vector
alone (pcDNA3) as described in Materials and Methods. Of
the several target proteins identiﬁed (Table 1), we focused on1211
Ismail et alGa12 because of its previously described roles in the biology
of TECs and AKI.9,20
To conﬁrm the mass spectrometric results, we performed
pull-down experiments by using S35methionine-labeled
KIM-1 from reticulocyte lysates with GST fused to Ga12 to1212determine whether Ga12 can interact directly with KIM-1.17
We found that KIM-1 with a c-terminal HA tag bound to
GST-Ga12 but not unconjugated GST (Figure 1A). Co-IP
of Ga12 and KIM-1 by using both antieKIM-1 and anti-
Ga12 but not the control antibody conﬁrmed this interactionajp.amjpathol.org - The American Journal of Pathology
KIM-1 Protects Against Renal IRI(Figure 1B). The cytosolic domain of KIM-1 was sufﬁcient
to mediate binding to Ga12 as indicated by co-IP of Ga12
with a truncated version of KIM-1 that contained its cyto-
solic domain fused to its transmembrane domain and an
extracellular FLAG tag (Figure 1C).7 To determine whether
activated Ga12 can also interact with KIM-1, we stimulated
KIM-1eexpressing HEK-293 cell lysates with GTPgS
before performing co-IP21; GTPgS stimulation of Ga12 did
not alter the interaction with KIM-1 (Figure 1D). To visu-
alize the interaction of Ga12 with KIM-1, HEK-293 cells
were cotransfected with KIM-1 and green ﬂuorescent pro-
tein-Ga12 and colocalization of both proteins was assessed
by confocal microscopy. A substantial proportion of KIM-1
was associated with Ga12 in cells expressing both proteins
as indicated by Pearson’s coefﬁcient (0.409  0.098; n Z
7) (Figure 1E). In addition, we found colocalization of both
murine Kim-1 and Ga12 in kidney tissue sections isolated
from C57BL/6 wild-type (Kim-1þ/þ) mice that were sub-
jected to renal IRI (bilateral renal pedicle clamping for 30
minutes followed by 24 hours of reperfusion) to allow for
Kim-1 up-regulation (Figure 1F). Taken together, these data
suggest that KIM-1 interacts constitutively with Ga12 via
its cytosolic domain, independent of Ga12 activation.
It has long been hypothesized that KIM-1 might play a
protective role in AKI.4 Given that Ga12 activation instigates
injury pathways in AKI, we hypothesized that KIM-1 might
suppress endogenous Ga12 activation in TECs. Because
Ga12 is activated by guanine nucleotide exchange, we stud-
ied its activation by using a GST-TPR pull-down assay.18
Figure 2A shows that endogenous Ga12 activity is inhibi-
ted in cells expressing KIM-1 but not the control vector. Next,
to test if KIM-1 expression could inhibit Ga12 activation by
physiologic ligands that stimulate its cognate G protein-
coupled receptors, we measured the amount of active Ga12
after stimulating HEK-293 cells transiently expressing
KIM-1 or control vector with a-thrombin (Figure 2B).9,20
Given that ROSs stimulate Ga12 activation in IRI, we
testedwhetherKIM-1 expression affectedGa12 activation by
H2O2; Ga12 activation was signiﬁcantly blunted in KIM-1e
expressing cells compared with control cells on stimulation
with either a-thrombin or 5 mmol/L H2O2 (Figure 2B). In
addition, we did not observe any effect of the amount of H2O2
used on cell viability (Supplemental Figure S2). Therefore,Figure 3 KIM-1edeﬁcient mice exhibit increased renal Ga12 activation and ti
Kim-1edeﬁcient (Kim-1/) mice underwent unilateral renal pedicle clamping for 3
renal cortical lysates obtained from clamped and contralateral kidneys by GST-TPR pu
total Ga12, mKim-1, and GAPDH. B: The amount of active pY419 compared with tot
treated as in A. Samples were analyzed by SDS-PAGE and Western blot analysis for in
Ga12 (or pY419-Src to c-Src) is shown as a representation of experiments. CeI: Ind
bilateral renal pedicle clamping for 30 minutes (CeE) or 25 minutes (FeI), follo
determined by plasma creatinine. D and G: Quantiﬁcation of tubular damage in who
reperfusion. I: Representative periodic acid-Schiffestained kidney sections after 48
tubular injury. Data are expressed as means SEM. nZ 3 per group in three indepe
group (FeI); nZ 9 per group (D and G). *P< 0.05, **P< 0.01, and ***P< 0.001.
3-phosphate dehydrogenase; Ga12, G protein a-12; GST-TPR, glutathione S-transfe
type 5; KIM-1, kidney injury molecule-1; mKim-1, mouse kidney injury molecule-1
The American Journal of Pathology - ajp.amjpathol.orgwe suspected that KIM-1 might block nucleotide exchange to
Ga12, thereby preventing its activation. To test this hypoth-
esis, we exposed lysates from HEK-293 cells transiently
transfected with either control vector or vector encoding
KIM-1 to GTPgS to irreversibly lock Ga12 in the active
conformation. We observed signiﬁcantly less GTP-bound
Ga12 in KIM-1eexpressing cells than in cells not express-
ing KIM-1 (Figure 2C). Similar results were obtained when
we used HEK-293 cells stably expressing KIM-1 or control
vector (results not shown).
To extend theseﬁndings to aphysiologically relevant in vitro
model,we comparedGa12activation inprimaryTECs isolated
from previously generated Kim-1edeﬁcient mice (Kim-1/)
(Figure 2D) to wild-type mice (Kim-1þ/þ). Concordant with
previous reports,22 Kim-1/ mice were phenotypically
normal. Ex vivo culture of TECs from Kim-1þ/þmice resulted
in KIM-1 up-regulation as previously reported,4 but it was
expectedly absent in TECs isolated from Kim-1/ mice.
Consistent with data in HEK-293 cells, we observed signiﬁ-
cantly higher amounts of active Ga12 in TEC lysates from
Kim-1/ mice compared with TEC lysates from Kim-1þ/þ
mice loadedwithGTPgS (Figure 2E). Similarly, the amount of
Ga12 activation was signiﬁcantly higher in TEC lysates from
Kim-1/ mice than that from Kim-1þ/þ mice on stimulation
with H2O2 (Figure 2F). Given that Src was found to intervene
the ROS/Ga12-mediated epithelial injury,9 we examined Src
activation by using pY419 antibodies (phosphorylated Src) in
the total cell lysates from Kim-1/ and Kim-1þ/þ TECs after
treatmentwithH2O2. Src activationwas signiﬁcantly enhanced
in TECs fromKim-1/mice comparedwith TECs fromKim-
1þ/þmice after H2O2 stimulation (Figure 2G). Taken together,
these data suggested that KIM-1 constitutively inhibits Ga12/
Src activation by blocking GDP-GTP exchange by Ga12.
To extend these ﬁndings to a physiologically important
model, we next determined whether up-regulation of KIM-1
by TECs during renal IRI would block pathogenic Ga12
activation in the kidneys by ROS. We subjected Kim-1þ/þ
and Kim-1/ mice to 35 minutes of unilateral renal artery
clamping, followed by 24 hours of reperfusion, and measured
Ga12 activation in the affected and contralateral kidney tis-
sues.9 As expected, we observed both an increase in Ga12
activation and an up-regulation in Kim-1 expression4,5 in the
reperfused kidneys but not in the contralateral (nonischemic)ssue damage after ischemia-reperfusion injury. A: Wild-type (Kim-1þ/þ) and
5 minutes, followed by 24 hours of reperfusion. Active Ga12 was measured in
ll-down assay, followed by SDS-PAGE and Western blot analysis for active and
al Src was measured by Western blot analysis in renal cortical lysates of mice
dicated antibodies. Densitometric analysis of the ratio of active Ga12 to total
ependent groups of Kim-1þ/þ and Kim-1/mice underwent sham surgery or
wed by 24, 48, or 168 hours of reperfusion. C and F: Kidney function was
le kidneys after 48 hours of reperfusion. E and H: Percentage of survival after
hours of reperfusion (Sham represents Kim-1/). Arrows indicate areas with
ndent experiments (A and B); nZ 5 to 11 per group (CeE); nZ 7 to 12 per
Scale barZ 0.10 mm. Original magniﬁcation,200. GAPDH, glyceraldehyde-
raseefused tetratricopeptide repeat domain of Ser/Thr protein phosphatase
; pY419, phosphorylated Src.
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Predictably, the degree of Ga12 activation after IRI was
signiﬁcantly higher in the kidneys from Kim-1/ mice than
in kidneys from the Kim-1þ/þ mice. Although there was a
small difference in active Ga12 amounts in the contralateral
kidneys between Kim-1/ and Kim-1þ/þ mice, it was not
signiﬁcant. In a parallel set of experiments, we also observed
increased Src activation in the total cell lysates from Kim-1/
kidneys compared with Kim-1þ/þ kidneys subjected to
ischemia-reperfusion consistent with previous ﬁndings
(Figure 3B).9,15
In view of the pathogenic role of activated Ga12 in IRI9
and the above data indicating that KIM-1 inhibits Ga12
activation, we hypothesized that Kim-1edeﬁcient mice
would show more severe IRI than Kim-1þ/þ mice. After 30
minutes of renal ischemia and 24 hours of reperfusion, renal
function was signiﬁcantly worse in Kim-1/ mice than in
Kim-1þ/þ mice (mean creatinine, 198 versus 87 mmol/L,
respectively; P < 0.01; nZ 9 per group) (Figure 3C). Kim-
1/mice also exhibited worse histologic renal damage than
did Kim-1þ/þmice (Figure 3D). After 48 hours of reperfusion,
7 of 11 Kim-1/ mice, whereas none of ﬁve Kim-1þ/þ mice
died (PZ 0.05) (Figure 3E). When we reduced ischemia time
to 25 minutes, Kim-1þ/þ mice maintained near-normal renal
function (mean creatinine, 17 mmol/L; nZ 11), whereas Kim-
1/micedeveloped severe renal impairment (mean creatinine,
111 mmol/L; nZ 12) (P< 0.001) after 48 hours of reperfusion
(Figure 3F). Tissue injury was also greater in Kim-1/ mice
than in Kim-1þ/þ mice (Figure 3G). After 168 hours of reper-
fusion, a signiﬁcant difference in renal function remained
between Kim-1þ/þ mice (mean creatinine, 17 mmol/L) and
Kim-1/ mice (mean creatinine, 43 mmol/L) (P < 0.01),
although4of 19Kim-1/mice and noneof 14Kim-1þ/þmice
died (PZ 0.067) (Figure 3, H and I).Discussion
AKI is a serious medical condition with no known treatment
and unresolved pathogenic mechanisms. It was recently
discovered that Ga12 has a crucial pathogenic role in renal
IRI.9,15 Speciﬁcally, ROS stimulates Ga12 to activate tubular
injury pathways, including disruption of tight junctions via
Src activation. To our knowledge, regulation of this pathway
has never been described. Here, we demonstrate that KIM-1
blocks GTP binding onto Ga12 and thus is an inhibitor of
Ga12 activation. In support of this ﬁnding, we found that
Kim-1/ mice exhibited exaggerated Ga12 and Src acti-
vation in vivo during renal IRI, compared with wild-type
mice. In addition, we observed worse renal dysfunction and
histology after bilateral pedicle clamping in Kim-1/ mice
than in wild-type mice. Taken together, our ﬁndings suggest
that KIM-1 protects against Ga12-mediated tissue damage
during ischemic AKI. Whether KIM-1 has additional, Ga12-
independent effects on TECs that protect from IRI is an area
of further study.231214Our results provide particular insight into the regulation
of G-protein signaling. Ga12, like all G proteins, is a mo-
lecular switch that is activated by GTP binding (on GDP
dissociation) and is inactivated when bound GTP is hy-
drolyzed to GDP.8 We found that KIM-1 reduces binding of
GTPgS to Ga12. To our knowledge, KIM-1 is the ﬁrst
guanine nucleotide dissociation inhibitor against Ga12 to be
identiﬁed.24 Interestingly, the cytosolic domain of KIM-1
does not contain the 19 amino acid sequence GoLoco
motif that is typical of guanine nucleotide dissociation in-
hibitor.25 The residues responsible for KIM-1 inhibition of
Ga12 are unknown. It is conceivable that targeting Ga12 by
using an exogenous chemical inhibitor might ameliorate
renal IRI.9 However, such an inhibitor does not exist and
may in fact be toxic, given that Ga12 is expressed ubiqui-
tously and also regulates many crucial cellular functions.8
Our results suggest that KIM-1 represents a natural,
endogenous mechanism to protect against tissue damage
during renal IRI. Given that KIM-1 is expressed by TECs
only during the injury and returns to baseline (undetectable)
amounts on renal recovery (after day 7 after IRI),26 Ga12
inhibition by KIM-1 is likely transient. Interestingly, the up-
regulation of KIM-1 seems to overlap with Ga12 activation
by ROS during ischemia-reperfusion. The down-regulation
of KIM-1 after AKI is equally important because condi-
tional overexpression of KIM-1 in TECs in the absence of
an injury stimulus results in kidney ﬁbrosis.27 It is proposed
that antagonizing KIM-1 signaling may represent a novel
therapeutic target to ameliorate renal ﬁbrosis in chronic
kidney disease. However, our identiﬁcation of KIM-1 in
regulating Ga12 and in protection against renal dysfunction
during IRI suggests that caution is warranted in targeting
KIM-1 in chronic kidney disease, as such a therapeutic
agent may exacerbate AKI episodes that are linked to pro-
gression of chronic kidney disease.28 It would also be
interesting to know if transiently overexpressing KIM-1
during IRI would further protect against tissue damage.
We speculate that strategies to enhance KIM-1 expression or
function may be particularly important in patients with
polymorphic variants of KIM-1 that might confer reduced
ability to inhibit Ga12.Acknowledgments
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